首页> 美国卫生研究院文献>Journal of Toxicologic Pathology >Relationship of Cell Proliferating Marker Expressions with PGE2 Receptors in Regenerating Rat Renal Tubules after Cisplatin Injection
【2h】

Relationship of Cell Proliferating Marker Expressions with PGE2 Receptors in Regenerating Rat Renal Tubules after Cisplatin Injection

机译:细胞增殖标志物表达与 顺铂后再生大鼠肾小管中的PGE2受体 注射

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cisplatin, an anticancer drug, is well known to have nephrotoxicity as an adverse effect. We investigated the expressions of cell cycle markers and prostaglandin E2 (PGE2) receptors (EP) in the affected renal tubules in rats injected with a single dose (6 mg/kg body weight) of cisplatin. On days 1–3 after dosing, the affected renal epithelial cells were almost desquamated, showing necrosis. On day 5 onwards, the renal tubules were rimmed by flattened or cuboidal epithelial cells with basophilic cytoplasm; BrdU-immunopositive cells began to significantly increase, indicating regeneration. Simultaneously, TUNEL-positive apoptotic cells were also seen. On days 1–5, cyclin D1-immunopositive cells were decreased with an increased expression in p21 mRNA, indicating G1 arrest in the cell cycle. The affected renal epithelial cells began to react to EP4 receptor, but not to EP2 receptor. Some EP4 receptor-reacting epithelial cells gave a positive reaction to BrdU or cyclin D1. Collectively, the affected renal tubules underwent various alterations such as necrosis, apoptosis, regeneration and G1 arrest; the aspects might be influenced by endogenous PGE2 through EP4 receptor.
机译:众所周知,顺铂是一种抗癌药,具有肾毒性。我们调查了单剂量(6 mg / kg体重)顺铂注射的大鼠受影响的肾小管中细胞周期标志物和前列腺素E2(PGE2)受体(EP)的表达。给药后第1-3天,受影响的肾上皮细胞几乎脱皮,显示坏死。从第5天起,肾小管被具有嗜碱性细胞质的扁平或立方形上皮细胞边缘化; BrdU免疫阳性细胞开始大量增加,表明有再生。同时,还观察到TUNEL阳性的凋亡细胞。在第1-5天,细胞周期蛋白D1免疫阳性细胞减少,p21 mRNA表达增加,表明G1在细胞周期中停滞。受影响的肾上皮细胞开始对EP4受体起反应,但对EP2受体不起反应。一些反应EP4受体的上皮细胞对BrdU或cyclin D1产生阳性反应。总的来说,受影响的肾小管经历了各种改变,例如坏死,凋亡,再生和G1停滞。这些方面可能受到通过EP4受体的内源性PGE2的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号